Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTRANASAL INSULIN TRIAL II
2009-017329-20Phase 2Terminated
- Sponsor
- Melbourne Health
- Start
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Intranasal insulin with Placebo (2 arms). Primary endpoint: Onset of diabetes. Started May 2010; status: terminated.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2009-017329-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017329-20.